Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06085118

Observatory on Cow's Milk Protein Allergy

Prospective National Observatory for Cow's Milk Protein Allergy.

Status
Recruiting
Phase
Study type
Observational
Enrollment
3,000 (estimated)
Sponsor
Nutricia Nutrition Clinique · Industry
Sex
All
Age
8 Months
Healthy volunteers
Not accepted

Summary

The purpose of this study is to describe the symptoms and their evolution up to the age of 5 years in a population of newly diagnosed infants with a suspected or confirmed allergy to cow proteins, for whom the doctor prescribed the Pepticate® Syneo® replacement formula as soon as they were diagnosed. The Pepticate® Syneo® product is an advanced protein hydrolyzate, food type intended for special medical purposes. This is a product already available on the market.

Detailed description

This is a prospective, observational, descriptive, longitudinal, multicentric study aimed at describing a cohort of infants with a recently suspected or confirmed allergy to cow's milk protein, who were treated in outpatient and inpatient settings. The recruitment of patients eligible for this observatory will be done via community medicine (private practices of pediatricians and general practitioners) as well as in hospitals throughout France.

Conditions

Interventions

TypeNameDescription
OTHERPepticate® Syneo®Introduction of the nutritional treatment Pepticate® Syneo® (high protein hydrolysate), as a foodstuff for special medical purposes (product already available on the market).

Timeline

Start date
2024-06-17
Primary completion
2031-11-01
Completion
2031-11-01
First posted
2023-10-16
Last updated
2024-06-25

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT06085118. Inclusion in this directory is not an endorsement.